US and China IP experts call for reforms to boost Chinese pharmaceutical industry
The US-China IP Cooperation Dialogue Report says that greater protection for innovators is needed to unleash the potential of China's pharmaceutical industry
The report, released last week by the Global IP Center of the US Chamber of Commerce, is the result of a series of meetings between some of the most prominent IP experts from China and the US including David Kappos...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.